Pica Eating Disorder Treatment Market

The global Pica Eating Disorder Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Pica is an eating disorder in which people eat nonnutritive substances which are not typically thought as food such as paper, cloth, soap, hair, wool, soil, chalk, string, talcum powder, gum, paint, metal, pebbles, charcoal, ash, clay, starch, or ice. This can lead to intoxication in children which may result in impairment of both mental and physical development. Pica eating disorder can occur in any age group. There is no such kind of laboratory tests for pica instead the diagnosis can be done clinically. Iron deficiency anemia and malnutrition are the most common cause of the pica. There are various pica eating disorder treatment options available by using dietary supplements, different therapies are also available like psychotic therapy, cognitive behavioral approaches, nutritional counselling etc. Diagnosis of pica can be accompanied by the test for anemia as pica can occur in people who are malnourished. A lead level should be check-in children who have eaten any paint or objects covered in paint for lead poisoning. Pica eating disorder can lead to surgical emergencies due to obstructions in the intestine and parasitosis. Pica eating disorder often occurs with the mental health disorders which are associated with impaired functioning and can be seen in pregnant women. The pica eating disorder treatment may vary from patient to patient and may have psychosocial, environmental and family guidance approaches. Iron deficiency can be treated by iron supplements.
Pica Eating Disorder Treatment Market aims to provide a comprehensive presentation of the global market for Pica Eating Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pica Eating Disorder Treatment. Pica Eating Disorder Treatment Market contains market size and forecasts of Pica Eating Disorder Treatment in global, including the following market information:

• Dietary Supplements
• Antipsychotic Drugs
• Antidepressants
• Mood Stabilizers

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Mail Order Pharmacies

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)
  

• Key companies Pica Eating Disorder Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Pica Eating Disorder Treatment revenues share in global market, 2022 (%)

• Novartis International AG
• GlaxoSmithKline plc.
• Merck KGaA
• Sun Pharmaceutical Industries Limited
• Glenmark Pharmaceutical
• Torrent Pharmaceuticals Ltd.
• Micro Labs Limited
• FDC Limited
• Emcure Pharmaceuticals
• Mankind Pharma